Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 2/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ERN1 | O75460 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.43 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.43 |
| ▸ | QDPR | P09417 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6741025 | 0.99 | MIF (0.48) | MIFXDHKDM4EGAAMAPT | |
| SCHEMBL6741783 | 0.89 | CYP19A1 (0.49) | ERN1CYP1A2CYP3A4MKNK1MKNK2 | |
| SCHEMBL6736802 | 0.86 | CYP19A1 (0.49) | MIFXDHKDM4EGAAMAPT | |
| SCHEMBL6740241 | 0.86 | ACVR1 (0.48) | KDM4EMAPTCYP1A2CYP3A4MKNK1 | |
| SCHEMBL6740852 | 0.85 | CYP3A4 (0.54) | KDM4EMAPTTDP1CYP1A2CYP3A4 | |
| SCHEMBL6740187 | 0.83 | TDO2 (0.48) | KDM4EGAACYP1A2CYP3A4CYP19A1 | |
| SCHEMBL6739711 | 0.82 | KDM4E (0.55) | MIFXDHKDM4EGAAMAPT | |
| SCHEMBL6736043 | 0.82 | AXL (0.59) | CYP1A2CYP3A4CYP2D6CYP2C9HSD17B1 | |
| SCHEMBL6741695 | 0.82 | TDO2 (0.47) | KDM4EGAACYP1A2CYP3A4CYP2D6 | |
| Bromide SCHEMBL11325605 | 0.80 | ERN1 (0.63) | KDM4EGAAMAPTMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6689798-B2 | STEROID ALPHA-HYDROXYLASE AND STEROID LYASE INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-02-10 | — | — | US | disclosed |
| US-20030149079-A1 | Novel benzofuran derivatives | DAIICHI PHARMACEUTICAL CO., LTD. | 2003-08-07 | — | — | US | disclosed |
| EP-1283208-A1 | NOVEL BENZOFURAN DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149079-A1 | Novel benzofuran derivatives | CYP17A1, CYP21A2, HSD17B7 | MIF 1434/4885XDH 78/4885KDM4E 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.